CIK 0001133869
- Non-accelerated filer
- Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 310-358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-02 | Smith Rachel Vice President of R&D | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2017-12-22 | Smith Rachel Vice President of R&D | Option exercise | +20,748 | $0.16 | $3K | 20,748 |
| 2017-12-22 | Smith Rachel Vice President of R&D | Shares withheld for taxes | −2,244 | $1.48 | $3K | 18,504 |
| 2017-12-22 | Smith Rachel Vice President of R&D | Option exercise · Stock Option (right to buy) | −20,748 | 0 | ||
| 2017-01-03 | Smith Rachel Vice President of R&D | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2016-06-02 | Smith Rachel Vice President of R&D | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 1 of 1 · 6 trades